Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmaco-Scintigraphic Study of TP05 Formulations in Healthy Subjects and UC Patients
NCT02306785Phase 1Completed
- Sponsor
- Tillotts Pharma AG
- Start
- Oct 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of Salcrozine in ulcerative colitis (UC) (3 arms), sponsored by Tillotts Pharma AG. Primary endpoint: Tablet release at 3 days. Started Oct 2012; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02306785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306785.